Catalyst Wire Dossier Catalyst Wire Dossier

Natroba Topical Suspension 0.9%

permethrin · Cipher Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Natroba Topical Suspension 0.9%, covering 2025-02-14 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies [Phase 4]

See pricing